Filing Flows › Rhythm Pharmaceuticals (RYTM) › Recalls, complaints & regulation
Rhythm Pharmaceuticals (RYTM): clinical trials
Rhythm Pharmaceuticals (RYTM) beyond its filings: 5 active clinical trials.
Rhythm Pharmaceuticals' latest quarter
Rhythm Pharmaceuticals, Q3 2026: revenue $92.1M (+80% year over year), operating margin -42.6%, net loss $41.4M, operating cash flow −$3.1M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Rhythm Pharmaceuticals have?
5 active studies on ClinicalTrials.gov, 2 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.